Evidence map›Paper›PMID 35392125›Full record

ArticleJournal of clinical and translational research2022

Impact of AmaTea® Max on physiological measures and gaming performance in active gamers: A placebo-controlled, double-blind, randomized study.

Richard J Bloomer, Keith R Martin, Jacquelyn C Pence

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of clinical and translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06848114 (The Effect of Posture and Scapular Position on Performance Parameters in E-sport Players), which is not on this map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06848114 completednot on this mapstarted 2023, after this paper: background citation

The Effect of Posture and Scapular Position on Performance Parameters in E-sport Players

Typeobservational_patient_registrySponsorÖmer BayrakRan2023 to 2024Enrolled27ConditionsScapular Dyskinesis, Shoulder Proprioception, Reaction Time, Physical Activity
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Richard J BloomerCenter for Nutraceutical and Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, Tennessee, United States.
Keith R MartinCenter for Nutraceutical and Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, Tennessee, United States.
Jacquelyn C PenceCenter for Nutraceutical and Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, Tennessee, United States.
University of Memphis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: The activity of "gaming" has increased greatly in popularity in recent years, with many gamers using nutritional supplements to aid mood and gaming performance. We evaluated the impact of AmaTea Methods: Subjects reported to the lab on three occasions, separated by approximately 1 week. On each day, they had baseline measurements taken and then played the game Fortnite for four 1-h periods. Measures of cognitive performance, gaming performance, heart rate and blood pressure (BP), and blood cortisol were measured before and at selected times following gameplay. Results: Neither caffeine nor AmaTea Conclusion: AmaTea Relevance for Subjects: Active gamers who seek to use a dietary supplement for purposes of gaming performance may benefit slightly from ingestion of AmaTea

Indexed as

AmaTea®caffeinegamingstimulants

Identifiers

PMID35392125
PMCPMC8983391
OpenAlexW4223555920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.